Christoph Barkhausen

Dr Christoph Barkhausen relocated to Brisbane in 2021 to become the first Radiochemistry Fellow at the Queensland NIF node. This role spans both the University of Queensland (CAI) and Queensland Health campuses (HIRF/RBWH). Christoph has a variety of research interests including the production of cyclotron and reactor-based radioisotopes, development and implementation of novel and routine radiopharmaceuticals and translational science supporting research to progress to clinical use.

Dr Barkhausen obtained his PhD in radiochemistry at the Technical University Munich (Germany) (thesis on n.c.a. 177Lu-production) in 2011. He has more than 15 years of radiochemistry expertise, accumulating experience in a wide range of positions including Head of Radiochemistry, Head of Quality Control, Head of Quality Assurance, Qualified Person. Prior to commencing as a NIF Radiochemistry Fellow he was responsible for the daily supply of 18F-, 11C-, 68Ga- and 15O-radiopharmaceuticals (FDG, FPSMA, DOPA, GaPSMA, PiB, etc.) to hospitals in Germany, France and Switzerland.

Deborah Hendle

Deborah (Deb) Hendle is the Administration Officer for NIF.  Deb completed a Bachelor of Arts where she Majored in International Relations and Organisational Communication.  She has been working In Administration and Finance for UQ since 2006 and now provides administrative support to the NIF Central management team. Deb contributes to the day to day operations of the National Imaging Facility project and is responsible for the processing of financial transactions as well as travel arrangements in accordance with UQ Finance & Business Services and UQ policies and procedures.

Wojtek Goscinski

Prof Wojtek Goscinski has over 20 years’ experience in the research and innovation sector as a leader in research, research infrastructure, high performance computing and imaging informatics. 

Prof Goscinski is the Chief Executive Officer of the National Imaging Facility (NIF), Australia’s advanced imaging network. NIF is a partnership of university, medical research institute and government science agency partners, that operates under the Commonwealth Government’s National Collaborative Research Infrastructure Strategy.

Prof Goscinski is an Adjunct Professor of Practice at Monash University, in the Faculty of Medicine, Nursing and Health Sciences.

Prior to this, he was the founding Coordinator and Platform Director of MASSIVE, a national high performance data processing and analytics facility at Monash University with national impact and an international profile.

Prof Goscinski is a member of the Scientific Advisory Committee for the Euro Bioimaging European Research Infrastructure Consortium, and chaired infrastructure and standards governance programs under the International Neuroinformatics Coordinating Faculty.

Saeed Shanehsazzadeh

Saeed Shanehsazzadeh, PhD, received his Ph.D. in medical physics from the Tehran University of Medical Sciences in 2013. In his post-doctoral career, he further specialized in nanoparticle tracer development and characterization and was able to make significant contributions in the field of antibody labelled radioisotopes. From more than 10 years research work in international molecular imaging, nanomedicine and multidisciplinary medical sciences labs in Iran, Germany, Belgium, Canada, Singapore and Australia, Saeed brings an impressive background into the UNSW node helping to bring MPI as a novel tracer imaging method to the next level.

Margaret Harding

Margaret Harding is an experienced Board Director and higher education Senior Executive. She is currently Board Chair of NSW Circular, non-Executive Director at SmartSat CRC, Professor Emeritus at the Australian National University and an Honorary Fellow at the National Measurement Institute.  She holds BSc (Hons), PhD and DSc degrees in chemistry from the University of Sydney.

Margaret has held Senior Executive roles in higher education, most recently serving as Deputy Vice-Chancellor (Research and Innovation) at the Australian National University for 6.5 years. She has been a Director on the Boards of ANU Enterprise Pty Ltd, Australian Scientific Instruments Pty Ltd, Neuroscience Research Australia Pty Ltd, Bionic Vision Australia Pty Ltd (Alternate Director) and has been a member of the Governing Boards of the National Computational Infrastructure, the National Centre for Indigenous Genomics and the Australia Indonesia Centre.

Paul Parizel

Paul M. Parizel graduated as MD, in 1982, summa cum laude from the Faculty of Medicine, University of Antwerp, Belgium. In 1994, he obtained a PhD with a doctoral dissertation entitled “The influence of field strength on magnetic resonance imaging.” He is a board-certified radiologist and neuroradiologist and completed fellowships in neuroradiology at Massachusetts General Hospital, Harvard Medical School, and at Hôpital Erasme, University of Brussels.
From 2003 until 2019, he served as Chair of the Department of Radiology at the Antwerp University Hospital, and tenured full Professor of Radiology in the Faculty of Medicine and Health Sciences, University of Antwerp. He was also a member of the Board of Trustees of the University of Antwerp, representing the Faculty of Medicine and Health Sciences.
Since 2019, prof. Parizel works in Australia as the “David Hartley Chair of Radiology”, with an academic appointment at the University of Western Australia (UWA) and a part-time clinical appointment at Royal Perth Hospital (RPH). He is the Chair of the Clinical Radiology Research Committee (CRRC) of the Royal Australian and New Zealand College of Radiology (RANZCR), Director of the Western Australian National Imaging Facility node, a member of the Academic Council at the University of Western Australia, and a member of the Centre for Innovation in Biomedical Imaging Technology Advisory Committee.
From 2010 to 2012, prof. Parizel served as President of the European Society of Neuroradiology (ESNR). He was elected President (2016-2017) and Chairman of the Board of Directors (2017-2018) of the European Society of Radiology (ESR). He is an Honorary Fellow of the Royal Australian and New-Zealand College of Radiology (2002), Honorary and Founding member of Russian National Society of Neuroradiology (2012), Honorary Member of the European Society of Neuroradiology (2016), Honorary Member of the American Society of Neuroradiology (2017), Honorary Member of the Radiological Society of North America (2018), and Honorary Member of the Serbian, Romanian, Spanish, Hellenic, French, Iranian, Israeli, Algerian, Swiss, Cuban, Italian, Peruvian, and Brazilian societies of radiology.
Prof. Parizel has authored or co-authored well over 400 peer-reviewed scientific papers, more than 40 book chapters, and has edited or co-edited several textbooks. His h-index is 50 (Scopus) and his scientific work has been cited over 9,000 times.
He remains a corresponding member of the Royal Academy of Medicine of Belgium and has been a member of the Harvard Club for more than thirty years.

Shenjun Zhong

Dr Shenjun Zhong is currently the research fellow and informatics officer in Monash Biomedical Imaging (MBI), Monash University. He obtained the doctoral degree in Monash University, working on diffusion MRI tractography and GPU CUDA C/C++ accelerated implementations (2016). Shenjun worked on various deep learning applications in medical imaging, including using CNN for MRI motion correction, object detection and image segmentation, and using LSTM for diffusion streamline embedding and generation. He worked as a data scientist in Telstra for large scale deep learning-based chatbots and NLP projects. Shenjun’s research interests are deep learning applications in computer vision and NLP, particularly in the medical imaging domain.

Georgios Angelis

Dr Georgios Angelis received his bachelor’s degree in Electrical and Computer Engineering from the National Technical University of Athens, Greece in 2007. He completed his Ph.D. in Biomedical Engineering at the University of Manchester, UK in 2011 working in the field of spatiotemporal (4D) Positron Emission Tomography image reconstruction and parameter estimation for applications in neuroscience. In 2012 he moved to Australia to pursue a postdoctoral position within the internationally recognised Imaging Physics group, based at the University of Sydney’s Brain and Mind Centre, which has pioneered the use of motion tracking and correction for quantitative imaging of conscious and freely moving rodents. He worked on challenging technical problems, such as the accurate modelling of animal motion within the imaging system, the complex photon attenuation field of a freely moving animal and the mathematical modelling of transient changes in neurotransmitter levels induced by cognitive tasks or pharmacological interventions. Before joining the Australian National Imaging Facility in 2020, he worked for 2 years as a senior research scientist at the Northern Sydney Cancer Centre, Royal North Shore Hospital, developing methods for real-time tumour tracking for motion adaptive radiotherapy. His current research interests include PET/SPECT image reconstruction and optimisation algorithms, pharmacokinetic modelling of physiological processes, machine learning and statistical analysis of multi-dimensional imaging data.

Graham Galloway

Professor Graham Galloway is the Chief Executive Officer of the National Imaging Facility (NIF). He has been instrumental in establishing Imaging collaborative research infrastructure in Australia. In 2006, he led the collaborative team that developed the Investment plan for Imaging, within NCRIS (National Collaborative Research Infrastructure Strategy). This plan was accepted by Department of Industry, Innovation and Science, with $7M Commonwealth funding, plus $10M state and institutional funding and Galloway was nominated by the Imaging Community as the Inaugural Chief Executive Officer of the National Imaging Facility. In this role, he provides leadership to the NIF as it develops a strategic vision for imaging in Australia. Under his leadership, NIF has expanded through the Education Investment Fund and further capital investment through NCRIS. With state and institutional funding, this is a $130M project. He is passionate about providing open access to the imaging resources and enabling effective use of those resources.

Graham’s research interests include the use of in vivo Magnetic Resonance to test the efficacy of pharmaceutical agents, novel applications for the use of Magnetic Resonance in physiological studies and material sciences, and in pushing the boundaries of the technology into new applications. His role in all projects is characterised by his multidisciplinary background, which ensures that he is able to draw together these apparently disparate threads.

Privacy Settings
Youtube
Vimeo
Google Maps
Save
We use cookies to enhance your experience while using our website. To learn more about the cookies we use and the data we collect, please check our Privacy Policy .
I Accept